top of page

Update on NET Clinical Trials

Join Dr. Heloisa Soares, a medical oncologist at the Huntsman Cancer Institute (HCI) at the University of Utah, to hear the latest in NET clinical trials.


profile pic 2 purple.JPG

Heloisa Soares, MD, PhD 

NETs & GI Medical Oncologist

Medical Director, Clinical Trials Office

Huntsman Cancer Institute, University of Utah

Dr. Heloisa Soares is a medical oncologist with a focus in GI and neuroendocrine cancers. She is an associate professor at the Huntsman Cancer Institute (HCI) at University of Utah. Dr. Soares received her medical degree at Faculdade de Medicine do ABC in Brazil, where she was born. 


She completed her residency training at the Mount Sinai Medical Center of Florida and her hematology-oncology fellowship training and PhD in molecular biology at UCLA. Dr. Soares has neuroendocrine tumors and gastrointestinal (GI) cancers as the major focus of her research and clinical activities. She serves as the Medical Director for the Clinical Trials Office as well as the co-physician leader in the GI Clinical Trials Research Group at HCI. 


In 2019, she was elected as a member of the board of directors for The North American Neuroendocrine Tumor Society (NANETS). Additionally, she is a member of the NCI NET taskforce and member of SWOG and NRG cooperative groups. She is also a panel member for the Neuroendocrine and Adrenal Tumors NCCN Clinical Practice Guidelines in Oncology.

Dr. Soares is a passionate advocate to patients and has, along many other patient-centered activities, volunteered at the ASCO Advocacy Summit on Capitol Hill and had the opportunity to meet members of congress and advocate to improve patient care.

You can follow her on Twitter at @helops79. 


Presentation Slides 

This information is provided by Dr. Soares for educational purposes only and does not substitute for medical advice. It is not approved for distribution or publication.


Ipsen_Logo (1).png
bottom of page